Today: 10 June 2026
Consumer cyclical stocks close higher into the weekend as XLY price steadies ahead of Fed, Tesla earnings

Consumer cyclical stocks close higher into the weekend as XLY price steadies ahead of Fed, Tesla earnings

New York, Jan 24, 2026, 12:56 PM ET — Market closed.

  • Shares in consumer cyclical sectors closed the week a touch up, following a choppy period in U.S. markets.
  • Amazon and Tesla, XLY’s top two holdings, continue to dominate its performance.
  • Midweek brings the next hurdle: the Fed’s policy announcement and Tesla’s earnings report.

The Consumer Discretionary Select Sector SPDR Fund (XLY), a key gauge for consumer cyclical stocks, ticked up 0.4% on Friday to finish at $123.13. That puts the fund roughly 0.7% higher for the week.

This matters since the group usually reacts quickly to shifts in expectations around U.S. growth and interest rates. When concerns over borrowing costs or consumer demand rise, these stocks are often the first to shift.

XLY is notably concentrated. Amazon and Tesla alone account for just over 40% of the fund. Following them are Home Depot, McDonald’s, Booking Holdings, and Starbucks among the biggest holdings.

The broader market closed Friday on a mixed note: the Dow dropped 0.58%, the S&P 500 held steady, and the Nasdaq ticked up 0.28%, following a week rattled by tariff news and risk-off moves. Intel plunged 17% after issuing a gloomy forecast, while big tech names like Amazon gained ground. One portfolio manager described the mood as a “show-me” phase ahead of earnings. Reuters

Late-week economic data offered little new direction for the sector. S&P Global’s flash U.S. composite PMI, an early gauge of business activity, remained in expansion mode for January. At the same time, the University of Michigan survey noted a rise in consumer sentiment, Reuters reported.

Valuations have upped the ante for the week ahead. FactSet put the S&P 500’s forward 12-month price-to-earnings ratio at 22.1, topping both its five- and 10-year averages. The firm also noted that 103 S&P 500 companies are set to report earnings this week. Consumer discretionary stood out as one of the sectors showing a year-over-year drop in earnings so far this season.

Reuters noted in a separate Week Ahead report that investors might shift focus from the Greenland tariff scare to earnings and the Fed’s interest rate outlook, with the central bank expected to keep rates unchanged on Wednesday. PNC’s Yung‑Yu Ma described recent sessions as a “short but steep roller-coaster ride.” Meanwhile, Franklin Templeton’s Chris Galipeau emphasized that “earnings are the driver” given current high valuations. Reuters

The calendar is packed. The Federal Reserve’s January timetable pins the two-day FOMC meeting on Jan. 27–28, with the policy statement dropping at 2:00 p.m. ET and Chair Jerome Powell’s press conference following at 2:30 p.m. ET on Jan. 28.

Tesla’s investor relations page pins Jan. 28 as the date for its quarterly earnings, slotting the major consumer-cyclicals player right in the thick of the Fed’s session.

But the flip side is clear. A return of tariff threats, a hawkish Fed pivot, or disappointing forecasts from key bellwethers could send the sector tumbling fast—especially since XLY’s gains hinge heavily on a handful of big names.

Looking ahead to the next session and the week, traders are zeroed in on two key questions: will the Fed stick to its soft-landing narrative on Jan. 28, and can Tesla’s report that day justify the sector’s premium valuations?

Stock Market Today

  • MindWalk Launches ReefIQ for Enhanced AI-Driven Drug Discovery
    June 10, 2026, 9:49 AM EDT. MindWalk Holdings Corp. (NASDAQ: HYFT) introduced ReefIQ™, a biological context layer designed to unify fragmented drug discovery data for AI analysis. The technology integrates diverse biological information such as sequences, structures, and assay results into a governed, queryable network. This enables MindWalk's LensAI tool and client-selected models to perform more accurate hypothesis generation and target discovery. By preserving data provenance and program history, ReefIQ aims to enhance trust and efficiency in regulated drug development environments. CEO Dr. Jennifer Bath emphasized that ReefIQ closes the data gaps in biological context, crucial for reliable AI-driven insights in life sciences.

Latest articles

Rigetti Computing Stock Falls as Sale Notice Tests $100 Million Quantum Rally

Rigetti Computing Stock Falls as Sale Notice Tests $100 Million Quantum Rally

10 June 2026
Rigetti Computing plunged 9.55% to $19.69 Tuesday and dipped further premarket after director Ray O. Johnson filed to sell 122,188 shares worth $2.6 million, testing investor confidence following a recent rally on news of a potential $100 million U.S. Commerce Department quantum-computing award, with traders watching for binding funding terms amid ongoing volatility.
PATH slips again, investors keep questioning AI automation bet

PATH slips again, investors keep questioning AI automation bet

10 June 2026
UiPath shares slid 3.76% to $10.75 and dropped another 1.49% pre-market as investors focused on slowing annual recurring revenue growth—up 12% to $1.901 billion versus 17% revenue growth—raising doubts about AI automation’s impact on recurring sales; second-quarter ARR guidance of $1.929–$1.934 billion is now the key number for PATH’s stock direction.
Cloud computing stocks face a packed week as Amazon job cuts loom and Fed meets
Previous Story

Cloud computing stocks face a packed week as Amazon job cuts loom and Fed meets

Tencent stock price: Nvidia H200 chip orders loom as 0700.HK heads into Monday
Next Story

Tencent stock price: Nvidia H200 chip orders loom as 0700.HK heads into Monday

Go toTop